Thus, hyperactivation of mTOR in many tissues during obesity causes defective glucose metabolism, increased fat storage, and insulin resistance and is, thus, an important target for the therapy of obesity-associated metabolic disorders. This evidence concerns the gene MTOR and metabolic disease.